Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nordion to Release Second Quarter 2013 Financial Results

Nordion to Release Second Quarter 2013 Financial Results

Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that the Company is scheduled to report its second quarter 2013 financial results after markets close on June 5, 2013.

Second Quarter 2013 Conference Call
The Company will also host an analyst conference call with Steve West, Chief Executive Officer and Peter Dans, Chief Financial Officer, to discuss the results. The call will be webcast live on June 6, 2013 at 10:00 a.m. ET.

The call will be webcast live on Nordion’s website at www.nordion.com, and will be available on the Company’s website after the call in archived format. Participants planning to dial into the call will need to register for the call and provide their full name, company name, phone number and email address to obtain the conference call coordinates. Registered participants will join the call using the coordinates (phone number, pass code, & personal PIN) provided during the registration process. The Self Registration URL link is as follows:

http://selfreg6.bellconferia.ca/webportal3/reg.html?Acc=1790302020&Conf=125106

About Nordion Inc.
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of targeted therapies, sterilization technologies and medical isotopes that benefit the lives of millions of people in more than 60 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has approximately 500 highly skilled employees worldwide. Find out more at www.nordion.com and follow us at http://twitter.com/NordionInc.

<div class="copyright"> Copyright Business Wire 2013 </div>


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today